CHALLENGING CASES

Browse all CHALLENGING CASES
Treating Complex Cases of EGFR-Mutated NSCLC

CHALLENGING CASES

Treating Complex Cases of EGFR-Mutated NSCLC

Eric Singhi, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Overcoming Challenges in Relapsed or Refractory FLT3-Positive AML

CHALLENGING CASES

Overcoming Challenges in Relapsed or Refractory FLT3-Positive AML

Naval Daver, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD, Uma Borate, MBBS

Selecting Bispecific Antibody Therapies in RR DLBCL

CHALLENGING CASES

Selecting Bispecific Antibody Therapies in RR DLBCL

Carla Casulo, MD, Tara Graff, DO, MS

NEW APPROVALS

Browse all NEW APPROVALS
FDA Approval of Zongertinib in HER2-Mutated NSCLC

NEW APPROVALS

FDA Approval of Zongertinib in HER2-Mutated NSCLC

Joshua Sabari, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

FDA Approves Dato-DXd for Patients With EGFR-Mutated NSCLC

NEW APPROVALS

FDA Approves Dato-DXd for Patients With EGFR-Mutated NSCLC

Jacob Sands, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

FDA Approval of Cabozantinib in Neuroendocrine Tumors

NEW APPROVALS

FDA Approval of Cabozantinib in Neuroendocrine Tumors

Aman Chauhan, MD

Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive Bladder Cancer

NEW APPROVALS

Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive Bladder Cancer

Thomas Powles, MD, MBBS, MRCP

TOX CHECK

Browse all TOX CHECK
Managing Side Effects of CDK4/6 Inhibitors in Breast Cancer

TOX CHECK

Managing Side Effects of CDK4/6 Inhibitors in Breast Cancer

Stephanie Graff, MD, FACP, FASCO, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Strategies to Minimize Side Effects in RCC Treatment

TOX CHECK

Strategies to Minimize Side Effects in RCC Treatment

Sumanta Pal, MD, FASCO, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Managing Side Effects of Panitumumab, Cetuximab, and Bevacizumab

TOX CHECK

Managing Side Effects of Panitumumab, Cetuximab, and Bevacizumab

Pashtoon Kasi, MD, MS

Managing Toxicities of FOLFIRINOX and Nab-Paclitaxel Plus Gemcitabine

TOX CHECK

Managing Toxicities of FOLFIRINOX and Nab-Paclitaxel Plus Gemcitabine

Midhun Malla, MD, Rachna Shroff, MD, MS, FASCO

TREATMENT ALGORITHMS

Browse all TREATMENT ALGORITHMS
Unraveling the Treatment Algorithm for Ovarian Cancer

TREATMENT ALGORITHMS

Unraveling the Treatment Algorithm for Ovarian Cancer

Sharyn N. Lewin, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Treating CML in 2025: TKIs and Transplant

TREATMENT ALGORITHMS

Treating CML in 2025: TKIs and Transplant

Jorge Cortes, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

CLL Treatment Landscape for the Community Oncologist

TREATMENT ALGORITHMS

CLL Treatment Landscape for the Community Oncologist

Mazyar Shadman, MD, MPH, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Myelofibrosis Treatment Algorithm in 2025

TREATMENT ALGORITHMS

Myelofibrosis Treatment Algorithm in 2025

Raajit Rampal, MD, PhD, Rahul Gosain, MD, MBA, Rohit Gosain, MD